Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
life sciences
national blog main
national top stories
new york blog main
new york top stories
san francisco blog main
san francisco top stories
sanofi
3
×
biotech
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
indiana blog main
indiana top stories
mammoth biosciences
national
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
acc
acceleron pharma
acid sphingomyelinase deficiency
acquisition
activist investor
aducanumab
allergan
alzheimer's disease
alzheimer's failure
What
week
3
×
bio
drug
roundup
aces
adu
announced
approved
beats
bids
big
biogen
black
ceo
cholesterol
companies
complicated
continue
debut
depression
diamond
diamond’s
dire
flexible
good
group
heart
help
inclisiran
indication
key
leading
life
lowering
mammoth
march
meant
medco
medical
medicine
Language
unset
Current search:
sanofi
×
week
×
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
4 years ago
As Cholesterol Drug Aces Big Test, MedCo CEO Open to Flexible Pricing
@xconomy.com
5 years ago
Bio Roundup: Sage Postpartum Help, Biogen Bids Adu, Heart Beats & More
